Study on the effect of surgical resection and continuous infusion of intratumoral chemotherapy on treatment of recurrent cerebral glioma

王明,尚寒冰,贾丕丰,张卫峰,李锋,顾威庭,卞留贯,赵卫国,蔡瑜

DOI: https://doi.org/10.3969/j.issn.1671-4695.2019.06.023

2019-01-01

Abstract:Objective To explore the efficacy of surgical resection and continuous infusion with intratumoral chemotherapy on recurrent cerrebral glioma. Methods A total of 114 eligible patients with recurrent glioma were selected according to the inclusion and exclusion criteria.Among them, 51 patients with surgical resection combined with interstitial sustained release chemotherapy (group A) and 63 patients with surgical resection alone (group B). All these patients received radiation therapy for 2 to 3 weeks after surgery. The difference in Karnofsky performance scale scores, recurrence rate and survival time between these two groups was statistically analyzed. Results There was no significant difference in preoperative general condition between these two groups. There was no significant difference in post-operative Karnofsky performance scale scores between these two groups [70 (60 ～ 80) vs. 70 (60 ～ 80) ] (P＞ 0. 05). The complete biodegradation of the carrier system in group A occurred one month after surgery. The recurrence rate of glioma in group A was not significantly different from that of group B in 6 months after surgery (16/51 = 31. 4％ vs. 25/63 = 39. 7％) (P＞ 0. 05), but the recurrence rates in 12 months and 24 months were 45. 1％ (23/51) and 62. 7％ (32/51) respectively, which were significantly lower than those of group B in 12 months (37/63 = 58. 7％) and 24 months of group A was 427. 5 d, it was significantly longer than the median survival period (211. 0 d) of patients in group B (P = 0. 001). Conclusion The continuous infusion of intratumoral chemotherapy with slow release polymer cisplatin can reduce the recurrence rate of tumor and prolong the survival period of patients with recurrent cerebral glioma.